These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 16762149)
1. Influenza virus haemagglutinin-derived peptides inhibit T-cell activation induced by HLA-DR4/1 specific peptides in rheumatoid arthritis. Li X; Li R; Li Z Clin Exp Rheumatol; 2006; 24(2):148-54. PubMed ID: 16762149 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides. Li X; Li R; Li Z Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between HLA-DR4/1 subtypes and T cell response to influenza virus hemagglutinin or anti-HA308-317 antibodies in rheumatoid arthritis]. Li X; Li R; Li ZG Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1881-3. PubMed ID: 19039998 [TBL] [Abstract][Full Text] [Related]
4. [The study of inhibitory peptides on T cell activation in rheumatoid arthritis]. Li X; Li R; Zhang CH; Li ZG Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(24):1679-82. PubMed ID: 16251070 [TBL] [Abstract][Full Text] [Related]
5. Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis. Li R; Li X; Li Z Clin Immunol; 2006; 118(2-3):317-23. PubMed ID: 16343992 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of T-cell activation with HLA-DR1/DR4 restricted Non-T-cell stimulating peptides. Zhou Q; Cheng Y; Lü H; Zhou W; Li Z Hum Immunol; 2003 Sep; 64(9):857-65. PubMed ID: 12941540 [TBL] [Abstract][Full Text] [Related]
7. Altered influenza virus haemagglutinin (HA)-derived peptide is potent therapy for CIA by inducing Th1 to Th2 shift. Sun J; Jia Y; Li R; Guo J; Sun X; Liu Y; Li Y; Yao H; Liu X; Zhao J; Li Z Cell Mol Immunol; 2011 Jul; 8(4):348-58. PubMed ID: 21383676 [TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation. Cheng YJ; Zhou Q; Li ZG Scand J Immunol; 2005 Mar; 61(3):260-5. PubMed ID: 15787743 [TBL] [Abstract][Full Text] [Related]
9. Superior molecularly altered influenza virus hemagglutinin peptide 308-317 inhibits collagen-induced arthritis by inducing CD4+ Treg cell expansion. Sun J; Li R; Guo J; Jia Y; Sun X; Liu Y; Li Y; Huang F; Lu L; Li Z Arthritis Rheum; 2012 Jul; 64(7):2158-68. PubMed ID: 22231228 [TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis. Skinner MA; Watson L; Geursen A; Tan PL Ann Rheum Dis; 1994 Mar; 53(3):171-7. PubMed ID: 8154934 [TBL] [Abstract][Full Text] [Related]
12. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation]. Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731 [TBL] [Abstract][Full Text] [Related]
13. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen. Rosloniec EF; Whittington KB; Zaller DM; Kang AH J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969 [TBL] [Abstract][Full Text] [Related]
14. Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells. Zhao J; Li R; He J; Shi J; Long L; Li Z Rheumatol Int; 2008 Nov; 29(1):9-16. PubMed ID: 18600328 [TBL] [Abstract][Full Text] [Related]
15. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401). Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912 [TBL] [Abstract][Full Text] [Related]
16. [Proliferation of type II collagen specific T cell response and antibody formation in rheumatoid arthritis and their relations to HLA-DR4]. Zhou Q; Li X; Li R; Zheng WY; Li ZG Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):370-3. PubMed ID: 15854524 [TBL] [Abstract][Full Text] [Related]
17. Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. Fridkis-Hareli M; Rosloniec EF; Fugger L; Strominger JL Hum Immunol; 2000 Jul; 61(7):640-50. PubMed ID: 10880734 [TBL] [Abstract][Full Text] [Related]
18. Lymphocyte responses to DR4/1-restricted peptides in rheumatoid arthritis. The immunodominant T cell epitope on the 19-kd Mycobacterium tuberculosis protein. Tan PL; Farmiloe S; Young J; Watson JD; Skinner MA Arthritis Rheum; 1992 Dec; 35(12):1419-26. PubMed ID: 1472121 [TBL] [Abstract][Full Text] [Related]
19. [Relationship between HLA-DR4/1 subtypes and T cell responses to type II collagen or anti-C II 263-272 antibodies]. Li X; Li R; Ning XR; Li ZG Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):582-4. PubMed ID: 16378106 [TBL] [Abstract][Full Text] [Related]
20. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis. Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]